PATENT CLAIM ANALYSIS

Application Number: 16025170
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["514", "043000"]

Abstract:
The present invention relates to compounds of formula (I), wherein R 1 , R 2  and R 3  are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.

Claim (Index 46):
A compound that is [(1S)-1-[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] 2-methylpropanoate, having the following structure: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14958619', '15207338', '15484015', '15809109', '15852108']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.829844132804362
- 35 USC 102 Novelty (BERT): 0.6905037260477523
- Combined Prediction Score: 0.815910092128701
- Mean Citation Score: 585.0926
- Max Citation Score: 726.8876
- Similarity Product: 679.1898385207893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test